0226 TIB preclin QT
BioCentury & Getty Images

Translation in Brief

A $53M UC Berkeley-UCSF-Genentech-Roche collaboration on brain diseases; plus Selecta, JDRF-Harvard Stem Cell Institute, Tissue Dynamics and more

BioCentury’s roundup of translational news

BioCentury’s roundup of translational news.

Feb 27, 2021 | 1:42 AM GMT

University of California Berkeley and University of California San Francisco announced Thursday a research collaboration with Genentech Inc. and Roche (SIX:ROG; OTCQX:RHHBY) to develop therapies for CNS disorders. The universities will receive up to $53 million over 10 years from Genentech. The partnership, dubbed

Read the full 841 word article

How to gain access

Continue reading with a
two-week free trial.